Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Aldeyra Therapeutics Inc (137.BE)

2.1560
-0.0030
(-0.14%)
As of 9:15:23 AM GMT+2. Market Open.
Loading Chart for 137.BE
  • Previous Close 2.1590
  • Open 2.1580
  • Bid 2.0390 x --
  • Ask 2.2630 x --
  • Day's Range 2.1560 - 2.1580
  • 52 Week Range 1.2775 - 6.5380
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 30, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 137.BE

View More

Performance Overview: 137.BE

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

137.BE
55.71%
S&P 500 (^GSPC)
8.60%

1-Year Return

137.BE
41.13%
S&P 500 (^GSPC)
6.00%

3-Year Return

137.BE
33.80%
S&P 500 (^GSPC)
25.85%

5-Year Return

137.BE
47.41%
S&P 500 (^GSPC)
89.51%

Compare To: 137.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 137.BE

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    127.30M

  • Enterprise Value

    51.67M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.06

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 137.BE

View More

Company Insights: 137.BE

Research Reports: 137.BE

View More